We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
-10.29%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.86B
AUM Growth
+$172M
Cap. Flow
-$26.2M
Cap. Flow %
-1.41%
Top 10 Hldgs %
17.46%
Holding
696
New
182
Increased
73
Reduced
54
Closed
240

Sector Composition

Rank Sector Weight
1 Financials 10.63%
2 Technology 5.95%
3 Industrials 3.82%
4 Energy 3.46%
5 Communication Services 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMAQR
451
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$44K οΉ€0.01%
400,000
– –
BREZR
452
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$39K οΉ€0.01%
+275,137
New +$43.9K
PAFOR
453
DELISTED
Pacifico Acquisition Corp. Rights
PAFOR
$28K οΉ€0.01%
174,938
+160,018
+1,073% +$50.1K
MCAFR
454
DELISTED
Mountain Crest Acquisition Corp. IV Rights
MCAFR
$13K οΉ€0.01%
+63,161
New +$20.2K
VTAQR
455
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$6K οΉ€0.01%
30,700
– –
AEON icon
456
AEON Biopharma
AEON
$12.9M
– –
-2,944
Closed -$2.06M
AISP
457
Airship AI Holdings
AISP
$60.3M
– –
-200,000
Closed -$1.96M
ASTLW icon
458
Algoma Steel Group Warrant
ASTLW
$242K
– –
-217,006
Closed -$2.35M
BLUE
459
DELISTED
bluebird bio
BLUE
– –
-8,539
Closed -$1.71M
CCSI icon
460
Consensus Cloud Solutions
CCSI
$670M
– –
-23,525
Closed -$1.36M
COCH icon
461
Envoy Medical
COCH
$51.7M
– –
-193,252
Closed -$1.88M
EHC icon
462
Encompass Health
EHC
$11B
– –
-251,397
Closed -$13.1M
EUDAW icon
463
EUDA Health Holdings Warrant
EUDAW
$268K
– –
-67,280
Closed -$656K
EXC icon
464
Exelon
EXC
$47.2B
– –
-160,163
Closed -$6.6M
GRFS
465
Grifois
GRFS
$5.36B
– –
-418,110
Closed -$4.7M
GSK icon
466
GSK
GSK
$104B
– –
-61,366
Closed -$3.38M
HPE icon
467
Hewlett Packard
HPE
$63.4B
– –
-211,979
Closed -$3.34M
INTC icon
468
Intel
INTC
$455B
– –
-65,282
Closed -$3.36M
KALV
469
DELISTED
KalVista Pharmaceuticals
KALV
– –
-92,000
Closed -$1.22M
LNZAW icon
470
LanzaTech Global Warrant
LNZAW
$3.98M
– –
-100,000
Closed -$966K
MDAI icon
471
Spectral AI
MDAI
$49.3M
– –
-464,451
Closed -$4.56M
OABI icon
472
OmniAb
OABI
$287M
– –
-200,000
Closed -$2M
OABIW icon
473
OmniAb Inc Warrant
OABIW
– –
-66,666
Closed -$667K
PTGX icon
474
Protagonist Therapeutics
PTGX
$8.79B
– –
-433,137
Closed -$14.8M
QNCX icon
475
CALL
Quince Therapeutics
QNCX
$22.9M
– –
-55
Closed -$139K

Similar funds

Mangrove Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Mangrove Partners held 696 positions worth $1.86B, up 10% from $1.68B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q1 2022 filing shows 182 new, 73 increased, 54 reduced and 240 closed positions. Its largest new stake was ZYNGA INC. CL A COMMON: 2,803,599 shares worth $25.9M. The largest sale was Xilinx Inc, an estimated $22.7M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Mangrove Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 2,803,599 shares worth $25.9M.
  • Mangrove Partners added most to Meta Platforms (Facebook) in Q1 2022, an estimated $8M increase.
  • Mangrove Partners's biggest Q1 2022 reduction was Magnachip Semiconductor, cutting an estimated $8.73M.
  • Mangrove Partners fully exited Xilinx Inc in Q1 2022, selling an estimated $22.7M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.86B portfolio in Q1 2022.
  • Mangrove Partners opened 182 new positions and closed 240 in Q1 2022.
  • Mangrove Partners's portfolio value rose 10% quarter-over-quarter to $1.86B.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.